Corporate Presentation May 7, 2026 Climb Bio Investor Presentation May 2026 R&D Spotlight Series May 5, 26 Budoprutug and the CD19 Opportunity Sep 29, 25 CLYM116 and the IgA Nephropathy (IgAN) Opportunity
